Immunotherapy and autoimmune diseases: A promising new approach
10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments
10Mar
10Mar
Immutep’s Pipeline: Progress in Immunotherapy and Autoimmune Treatments
10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth
07Mar
Navigating the Choppy Waters: Garry Crole on Market Greed, Fear, and the Perils of Passive Investing
07 Mar 2025 - Markets, valuations, and volatility: What investors need to know
03Mar
Immuno-oncology: Challenges, alternatives, and the future of cancer treatment
03 Mar 2025 - Addressing Unmet Needs in Cancer Care
24Feb
The future of immunotherapy: A growing market and a revolutionary approach
24 Feb 2025 - Immuno-oncology’s Expanding Role in Cancer Treatment
07Feb
Investing in mid-scale property
07 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.
05Feb
The future of long-range wi-fi: How Morse Micro is revolutionising connectivity
05 Feb 2025 - CEO Andrew Terry discusses long-range wi-fi, semiconductor challenges, and the future of IoT connectivity.
03Feb
Investing in mid-scale property
03 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.
16Jan
Bitcoin – Ethics, valuation and volatility
16 Jan 2025 - Off the Chain Capital's CIO Brian Estes discusses Bitcoin's ethical implications, investment metrics, and future outlook.
13Dec
Market update with Shaw and Partners, December 2024
13 Dec 2024 - Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.